Jmir Cancer

Jmir Cancer

杰米尔巨蟹座

  • 3区 中科院分区
  • Q3 JCR分区

期刊简介

《Jmir Cancer》是由JMIR Publications出版社创办的英文国际期刊(ISSN: 2369-1999),该期刊长期致力于肿瘤学领域的创新研究,主要研究方向为ONCOLOGY。作为SCIE收录期刊(JCR分区 Q3,中科院 3区),本刊采用OA未开放获取模式(OA占比1%),以发表肿瘤学领域等方向的原创性研究为核心(研究类文章占比88.28%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在145篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Jmir Cancer审稿周期约为12 Weeks。该刊近年未被列入国际预警名单,年发文量约145篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 145 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学
3区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学
3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY ESCI Q3 196 / 333

41.3

学科:ONCOLOGY ESCI Q3 196 / 333

41.29

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY ESCI Q3 171 / 328

48

学科:ONCOLOGY ESCI Q3 170 / 328

48.32

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY ESCI Q2 118 / 322

63.5

学科:ONCOLOGY ESCI Q2 161 / 322

50.16

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:4.1 SJR:0.798 SNIP:0.94
学科类别 分区 排名 百分位
大类:Medicine 小类:Oncology Q2 213 / 428

50%

大类:Medicine 小类:Cancer Research Q3 156 / 233

33%

期刊发文

  • Fear of Cancer Recurrence Before Treatment in Patients Newly Diagnosed With Breast Cancer: Cross-Sectional Stud

    Author: Ding, Yun; Zhang, Huiting; Zhong, Qiaoling; Zhang, Lijuan; Qin, Huiying

    Journal: JMIR CANCER. 2026; Vol. 12, Issue , pp. -. DOI: 10.2196/89346

  • Co-Ablation System for Pain Management in Bone Metastases: Retrospective Exploratory Stud

    Author: Yuan, Hang; Xia, Wei-Li; Song, Ho-Young; Zheng, Lin; Fan, Wei-Jun; Hu, Hong-Tao

    Journal: JMIR CANCER. 2026; Vol. 12, Issue , pp. -. DOI: 10.2196/86301

  • Immunotherapy Safety in Thymic Epithelial Tumors: Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting Syste

    Author: Chen, Ruilian; Chen, Hanrui; Sun, Lingling; Cao, Yang; Lin, Lizhu

    Journal: JMIR CANCER. 2026; Vol. 12, Issue , pp. -. DOI: 10.2196/76908

  • Prognostic Value of Dynamic Lactate Dehydrogenase Trends in Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma: Retrospective Cohort Stud

    Author: Zhang, Baidong; Kang, Zhichao; Ding, Yi; Jing, Wang; Feng, Alei; Zeng, Renya; Li, Jianan; Zhao, Yi; Nie, Yuanliu; Zhang, Wentao; Sun, Lu; Yang, Zhe

    Journal: JMIR CANCER. 2026; Vol. 12, Issue , pp. -. DOI: 10.2196/73576

  • Surrogate Decision-Making by Family Caregivers for Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer: Qualitative Study in a High-Volume Chinese Cente

    Author: Tan, Zheng-Ke-Ke; Li, Dan-Ni; Jia, Kui; Tang, Wen-Zhen; Chen, Xin; Yang, Li

    Journal: JMIR CANCER. 2026; Vol. 12, Issue , pp. -. DOI: 10.2196/80471

  • Reinforcement Learning-Based Digital Therapeutic Intervention for Postprostatectomy Incontinence: Development and Pilot Feasibility Stud

    Author: Fan, Fan; Huang, Hao; Yan, Jingwen; Xu, Chao-Yue; Wu, Xiuhua; Zhou, Chunmei; Wen, Dandan; Huang, Hai; Li, Ho Cheung; Qiu, Yihong

    Journal: JMIR CANCER. 2026; Vol. 12, Issue , pp. -. DOI: 10.2196/83375

  • AI-Based Identification Method for Cervical Transformation Zone Within Digital Colposcopy: Development and Multicenter Validation Stud

    Author: Wu, Tong; Wang, Yuting; Cui, Xiaoli; Xue, Peng; Qiao, Youlin

    Journal: JMIR CANCER. 2025; Vol. 11, Issue , pp. -. DOI: 10.2196/69672

  • Analyzing Online Search Trends for Kidney, Prostate, and Bladder Cancers in China: Infodemiology Study Using Baidu Search Data (2011-2023

    Author: Lin, Shuangquan; Duan, Lingxing; Xu, Xiangda; Cao, Haichao; Lu, Xiongbing; Wen, Xi; Wei, Shanzun

    Journal: JMIR CANCER. 2025; Vol. 11, Issue , pp. -. DOI: 10.2196/57414